Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

Evotec Appoints Christian Wojczewski as CEO (2024-04-23)
The Supervisory Board of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has appointed Dr Christian Wojczewski as the Company’s new Chief Executive Officer (“CEO”), effective 01 July 2024. The election was unanimous and...
Cultimate Foods Raises €2.3m Seed Funding Led by HTGF (2024-04-23)
Cultimate Foods, a biotech startup based in Berlin’s Biocube and Hannover (Institut für Technische Chemie, Leibniz Universität Hannover), successfully closes its seed round to scale up production processes, expand commercial collaborations and operation. The...
Domain Therapeutics Appoints Sean A. MacDonald as CEO (2024-04-17)
> Sean will drive the Company through its next phase of growth and bring its highly promising pipeline through clinical development > He brings more than 20 years of senior executive experience in the life science industry across business development, operations...
Medincell & AbbVie: up to $1.9b for Long-acting Injectables (2024-04-16)
> Medincell will receive an upfront payment of $35 million and is eligible for up to $1.9 billion in potential development and commercial milestones, plus royalties on worldwide sales. > Medincell and AbbVie will co-develop, and AbbVie will commercialize up to s...
Naobios and Sumagen Partner to Develop HIV Vaccine (2024-04-15)
Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of viru...
Ipsen Licenses Worldwide Rights to ADC STRO-003 from Sutro (2024-04-02)
> Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completing the final stages of pre-clinical development > STRO-003 targets ROR1, a clinically validated antibody drug conjugate (ADC) target ...
Sparxell Raise $3.2m in Seed Investments, Grants & Awards (2024-04-02)
Sparxell, the UK-based developer of high-performance, sustainable, plant-based pigments, has completed a $3.2m funding round (comprising seed investments, grants, and awards) to accelerate development and commercialisation of products which will eliminate synthetic...
SurgeCare Closes 2nd Funding Round of €7.5m led by Eurazeo (2024-03-27)
Surge, specialized in high-dimensional immune system analysis combined with artificial intelligence, is paving the way for a new era of precision medicine. With the launch of PreCyte®, its flagship product predicting post-operative complications, and the inaugurat...
Kranus Health Adds $5m to Series A Round to Expand Business (2024-03-25)
Kranus Health, the global leader in virtual care in urology, is announcing a substantial increase in its Series A funding by USD 5 million, bringing its total company funding to over USD 20 million. This new investment round brings Kranus Health into the forefront ...
Tricares Appoints Ahmed Elmouelhi as CEO (2024-03-25)
TRiCares SAS (“TRiCares”) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer (CEO). In conjunction with this, a...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

» Start here with the latest News!

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)